University of Texas at Tyler

Scholar Works at UT Tyler
MSN Capstone Projects

School of Nursing

Fall 12-5-2021

Ventilator-Associated Pneumonia Bundle Care
Jeemole Kattezham Binnichan
JBinnichan@patriots.uttyler.edu

Follow this and additional works at: https://scholarworks.uttyler.edu/nursing_msn
Part of the Nursing Commons

Recommended Citation
Binnichan, Jeemole Kattezham, "Ventilator-Associated Pneumonia Bundle Care" (2021). MSN Capstone
Projects. Paper 130.
http://hdl.handle.net/10950/3793

This MSN Capstone Project is brought to you for free and open access by the School of Nursing at Scholar Works
at UT Tyler. It has been accepted for inclusion in MSN Capstone Projects by an authorized administrator of Scholar
Works at UT Tyler. For more information, please contact tgullings@uttyler.edu.

Running head: VENTILATOR-ASSOCIATED PNEUMONIA BUNDLE CARE
1

Ventilator-Associated Pneumonia Bundle Care
A Paper Submitted in Partial Fulfillment of the Requirements
For NURS 5382: Capstone
In the School of Nursing
The University of Texas at Tyler
by
Jeemole K Binnichan
December 5, 2021

VENTILATOR-ASSOCIATED PNEUMONIA BUNDLE CARE
2

Contents
Acknowledgements
Executive Summary
Implementation and Benchmark Project
1. Rationale for the Project
2. Literature Synthesis
3. Project Stakeholders
4. Implementation Plan
5. Timetable/Flowchart
6. Data Collection Methods
7. Cost/Benefit Discussion
8. Discussion of Results
Conclusions/Recommendations
References
Appendix

VENTILATOR-ASSOCIATED PNEUMONIA BUNDLE CARE
3

Acknowledgments
I want to thank Lord Jesus Christ for instilling the courage and faith to pursue this degree,
whose absence would make this task impossible. Thank my parents, whose never-ending
support, guidance, and encouragement helped me soar in my educational journey. Although my
father is no longer with me, his inspiration and high hopes for his daughters will never be
forgotten. The instructors I have had the pleasure of working with these past few semesters have
given me unending support and motivation to allow this project to come to fruition. I have
sincere gratitude for their efforts. Thank you to my husband, K.E. Binnichan, for supporting my
dreams in pursuing my Master’s and encouraging me to do my best and my children Ashley and
Alvy.

VENTILATOR-ASSOCIATED PNEUMONIA BUNDLE CARE
4

Executive Summary
Ventilator-associated pneumonia (VAP) is one of the most significant nosocomial
infections in intensive care units (ICU) worldwide. Patients who have this infection due to
lengthy hospital stays face excessive hospital expenditures and are forced to spend more time
away from their families than is necessary. VAP is a prominent cause of morbidity and mortality
in ICUs, prompting plenty of studies. The most crucial target is its prevention. Understanding
how to reduce VAP would help patients live longer, have a better quality of life, and reduce
hospital liability. Ventilator-associated pneumonia bundle (VAPB) has been shown in numerous
studies to be an effective treatment for VAP prevention. Healthcare professionals are responsible
for providing evidence-based care to avoid complications and improve patient outcomes. The
recent SARS-CoV-2 pandemic made the condition worse. The admitting diagnosis of many
patients in ICU is pneumonia. In the current situation, each health care worker is more
responsible for avoiding additional healthcare-associated infections to patients.
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Ventilator-associated pneumonia bundle care
Ventilator-associated pneumonia is a nosocomial infection, and it occurs because of poor
patient care after intubation and mechanical ventilation. It leads to complications of patients,
including death, and increases the health care cost. In order to avoid this hospital-acquired
infection, health care providers must understand the importance of following VAP bundle care.
Health care professionals are responsible for providing evidence-based care to avoid
complications and improve patient outcomes. The project is based on the Ventilator-Associated
Pneumonia bundle, and due to COVID-19, nearly all patients were admitted with pneumonia,
and the likelihood of receiving a patient with a negative diagnosis was slim to none. Due to this
factor, the project's primary aim was to obtain VAP bundle compliance and adherence rate at
100%.
Rationale for the Project
Evidence-based care enhances healthcare quality, patient outcomes, clinician
empowerment, and cost-cutting; however, healthcare practitioners must provide evidence-based
care to reduce complications and improve patient outcomes (Melnyk & Fineout-Overholt, 2019).
VAP is a hospital-acquired infection (Haque, Sartelli, McKimm, & Abu Bakar, 2018), and the
objective of the study is to attain the goal of 100% adherence to VAPB protocol and, at the same
time, make nurses understand the need to implement the VAPB protocol strictly as VAP
infection is one of the more costly and debilitating nosocomial illnesses. VAP diagnosis is
challenging because radiological and clinical signs are inaccurate and associated with various
respiratory diseases (Timsit, Esaied, Neuville, Bouadma, & Mourvillier, 2017). Many studies
proved that VAPB treatment is effective for decreasing the incidence of VAP.
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The mortality rate linked to VAP varies between studies; however, VAP results in an
additional 12-day hospital stay and a cost increase of nearly $ 40,000 per episode, and
approximately 33% of VAP patients die due to the illness (Rodrigues, Fragoso, Beserra, &
Ramos, 2016). According to Efrati et al. (2010), VAP is still a common and expensive
complication of critical illness, with a pooled relative risk of 9-27 % and fatality rates of 25-50%.
The proposed approach for preventing VAP is to use the VAPB protocol at regular intervals and
is supported by several studies. If change is not implemented, hospitals must spend additional
money on treating VAP because it is a healthcare-associated infection (HCAI).
In 1981, the first Centers for Disease Control and Prevention (CDC) guideline for
preventing nosocomial pneumonia was published, which addressed the major infection-control
issues associated with hospital-acquired pneumonia ("Guidelines for Preventing Health-Care-Associated Pneumonia, 2003," 2019). The CDC guideline for nosocomial pneumonia prevention
was amended and expanded upon in 1994 by the Healthcare Infection Control Practices
Advisory Committee (HICPAC) (then known as the Hospital Infection Control Practices
Advisory Committee) ("Guidelines for Preventing Health-Care--Associated Pneumonia, 2003,"
2019). The Centers for Medicare and Medicaid Services (CMS), as the most prominent national
payer of healthcare in the United States, was the first to impose financial disincentives in an
attempt to enhance the quality of care through the healthcare-associated conditions (HAC) policy
in 2008 (Vaz et al., 2015). CMS halted additional reimbursements to hospitals for costs of care
connected with billing codes for certain "preventable events" because of HAC policy (Vaz et al.,
2015).
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Literature Synthesis
An extensive literature search was conducted on the topic of VAP through the databases
of the Cumulative Index to Nursing and Allied Health Literature, PubMed, and the Cochrane
Database of Systematic Reviews. Articles written from 2010 and English language are used as
the limiters for the search. The keywords used for the search included head of the bed elevation,
oral suction, oral care, sedation vacation, mechanical ventilation, VAP, and VAPB. The
literature review helps assess the effects of maintaining or enforcing the VAP bundle strategy to
prevent VAP in mechanically ventilated patients. The effect of VAPB adherence on VAP was
searched in the studies, and all studies confirmed that VAPB adherence contributes to lower
VAP rates (Balkhy, Al-Thaqafy, Arabi, & El-Saed, 2014; Bird, 2010; Mahmudin et al., 2020).
Three quasi-experimental studies were evaluated, both of which looked into the effectiveness of
VAPB in preventing VAP cases (Caserta et al., 2012; Eom et al., 2014; Fortaleza, Filho, Silva,
Queiroz, & Cavalcante, 2020). According to Eom et al. (2014), VAPB reduced the VAP rate
from 57 to seven instances per 1,000 ventilator days after VAPB was introduced. In contrast,
Fortaleza et al. (2020) found that the rate decreased from 34.95 to 13.27 in the first ICU and
from 36.58 to 12.04 per 1,000 ventilator days in the second ICU after VAPB was introduced.
The VAPB is an effective tool to prevent VAP, which is also supported in two other studies.
Though one study is methodological (Balkhy et al., 2014) and the other is descriptive
(Mahmudin et al., 2020), both found that the VAP rate dropped dramatically from 3.6 to 1.0 and
from 10.2 to 3.4 cases per 1,000 ventilator days, respectively.
A single randomized control trial by Shahabi, Yousefi, Yazdannik and Alikiaii (2016)
investigated the impact of a daily sedation interruption regimen on the early occurrence of VAP
in patients receiving mechanical ventilation in critical care units. The incidence rate of VAP in
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the intervention and control groups was 0% against 15% on the third day of the intervention,
12.5% compared 50% on the fourth day, and 27.7% versus 55.3% on the fifth day of intervention
(Shahabi et al., 2016). Infusion of a daily sedation vacation protocol dramatically reduced the
occurrence of VAP in patients receiving intravenous sedation, according to the findings of this
study. Shahabi et al. (2016) noted that VAP is one of the most prevalent and hazardous side
effects of mechanical ventilation. The main components of the VAPB included were head of the
bed (HOB) elevation and daily sedation vacation (Balkhy et al., 2014; Caserta et al., 2012; Eom
et al., 2014; Bird, 2010; Mahmudin et al., 2020; Fortaleza et al., 2020). Oral care was one VAPB
component in many studies (Balkhy, et al., 2014; Caserta et al., 2012; Eom et al., 2014;
Mahmudin et al., 2020; Fortaleza et al., 2020). Peptic ulcer prophylaxis and deep vein
thrombosis prophylaxis were also added in some studies as VAPB components (Balkhy et al.,
2014; Eom et al., 2014; Bird et al., 2010).
In a cohort study, VAP incidence dropped from 12.9/1000 ventilator-days (a rate of 16
cases per 100 patients) to 9.28/1000 ventilator-days (a rate of 11 cases per 100 patients)
following the VAPB intervention period (p 0.05) (Rello et al., 2013). A single-blind prospective
randomized clinical trial(Hassankhani, Akbarzadeh, Lakdizaji, Najafi, & Mamaghani, 2017)
evaluated the effects of 60° semi-recumbent position on preventing VAP and respiratory
parameters in mechanically ventilated patients. Significant decrease in VAP occurrence and
improvement in some mechanical respiratory parameters, including tidal volume and pulmonary
compliance, were noted with the HOB elevation of 60 degrees (Hassankhani et al., 2017). A
prospective, interventional, and multicenter study was conducted by (Álvarez-Lerma et al., 2018)
and found that implementing a bundle of measures to prevent VAP was associated with a highly
significant reduction of VAP from 9.83 episodes during the baseline period to 4.34 episodes per
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1,000 days of mechanical ventilation in the last three months of the intervention period. (Güner
& Kutlutürkan, 2021) conducted a prospective, randomized, controlled trial and investigated the
impact of semi-recumbent position at 30° and 45°on the development of VAP compared with a
HOB elevation to <30°. The frequency of VAP was significantly lower in the 45° compared with
the <30° study arm (P = .022) (Güner & Kutlutürkan, 2021).
Even though there is a clear link between the following VAPB protocol and lowering
VAP, implementing or enforcing VAP is challenging too. Atashi, Yousefi, Mahjobipoor, &
Yazdannik (2018) discussed three crucial categories of obstacles to preventing VAP in a single
qualitative/descriptive study: nurses' limited technical ability, unpleasant environmental
variables, and passive human resource management. However, proper funding, adequate staffing
levels, and contextually relevant evidence-based guidelines are essential to successful VAP
prevention.
Project Stakeholders
The stakeholders in this project included the patients, family members, doctors,
especially pulmonologists, staff nurses, critical care charge nurses, members from the
respiratory, radiology department, infectious control and prevention nurse, members from
hospital supply department, and hospital administration. Stakeholder support is crucial so that
evidence-based change can occur in the hospital, leading to positive outcomes. When
implementing evidence-based change, it is crucial to think about the preferences of patients and
stakeholders because their support is crucial to the initiative's success (Melnyk & FineoutOverholt, 2019). Timely notification about the project's progress to the critical care director and
director of the respiratory department was crucial. Charge nurses were other resource personnel
for this project; they took additional responsibility to assess the VAPB compliance checklist in
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each shift. Nurses and respiratory technicians worked for hand in hand for the success of this
project. All ventilated patients underwent chest radiographs in the morning every day, and
members from the radiology department were additional resource personnel. The
pulmonologist's support was crucial in this journey to diagnose and confirm patients' problems.
The hospital's supply department was responsible for providing enough materials, especially
mouth care kits and suction materials. Approval from hospital administration was necessary for
the implementation of the project.
Incorporating patient preferences for healthcare into the method of care and scientific
decision-making is an essential function of patient-centered care, adheres to moral standards of
respect and autonomy, and in many cases, contributes to better health outcomes (Street, Elwyn,
& Epstein, 2012). Communication is critical in patient-provider relationships. It is critical to
inform the patient and their family members about the VAPB intervention and why it is
performed. The provider must give tailored care based on the patient's needs and unique medical
history (Melnyk & Fineout-Overholt, 2019). When presenting treatment plans or possibilities
and the full extent to which the patient will be affected by treatment, healthcare providers must
evaluate the advantages of embracing patient values and requirements (Siminoff, 2013).
In the case of ventilated patients, an affected person cannot voice their worries and may
be bodily or cognitively incapable of letting their providers recognize their options. In such
circumstances, it was up to the nurse or physician to successfully communicate with the afflicted
person's family about what methods or actions might be done to move forward. Healthcare
providers must ease the tensions of anxious family members when their loved ones are
mechanically ventilated and are showing signs of severe discomfort. For example, when sedation
has ceased, the patient will become increasingly agitated and uncomfortable, which may be
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troubling for the family members to witness in the room. A proper explanation should be given
to walk the family members through the process to know what to expect next. This phase is
particularly critical for establishing trust and rapport with patients and those who care for them.
Implementation Plan
The evidence-based project selected was the implementation of the revised VAPB for
the prevention of VAP. The change project was selected, and the PICOT question was developed
in January 2020, but implementation started only in September 2021. First secured approval
from the hospital, and the current project implemented at Dallas Regional Medical Center's
(DRMC) 14 bedded surgical intensive care unit (SICU).
VAP is defined as an infection of the lung parenchyma that occurs at least 48 hours after
hospital admission (Timsit et al., 2017). Initially, the plan was to select ventilated patients with
no pneumonia at the time of intubation. However, the condition changed, and due to COVID-19,
almost all patients were diagnosed with pneumonia at the time of admission. There was no
possibility to get patients with no pneumonia at the time of admission. Numerous studies have
demonstrated the usefulness of the VAPB so the goal for this initiative is to attain 100 percent
VAPB compliance that ultimately prevents VAP.
SICU receives all ventilated patients admitted to the hospital. Only ventilated patients in
the SICU were included in the current project. The proposed VAPB includes daily sedation
vacation, assessment for readiness to extubate, HOB elevation at least 30 degrees or more (unless
contraindicated), gastric ulcer prophylaxis, deep vein thrombosis prophylaxis, cuff pressure
control (cuff pressure assessment at least once in a shift), oral care, and oral suction every four
hours.
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COVID-19 prolonged intubation days and endotracheal tube (ETT) cuff leak and
reintubation are in place, even though there are very few numbers. To avoid this unwanted
dangerous situation, advocated for adding cuff pressure monitoring at least once in a shift. In
many studies, cuff pressure assessment was one of the VAPB components that allowed for
proper care and increased patients' long-term health (Mahmudin et al., 2020; Rello et al., 2013).
This addition was made due to extreme necessity since the pandemic began, changing how
clinicians care for patients.
The study period was for four weeks, from October 17 to November 13, 2021. Each
assigned nurse or respiratory therapist was responsible for providing recommended VAPB care
to the patient and recording it in electronic health records (EHR). Nurses and respiratory
technicians must work hand in hand for the success of this project. Inter-professional
collaboration is frequently utilized to solve a wide range of challenges and complex situations
when two or more professions collaborate to achieve a common goal (Green & Johnson, 2015).
The hospital uses epic software for EHR, including VAP on the property list. Each nurse and
respiratory therapist could add VAP to the property list on the flow sheet. Staff members were
responsible for clearing their worklist hourly, which also helped implement the VAPB every four
hours.
Some of the essential elements needed for successful organizational change management
include frequent and effective communication, fostering a team culture, identifying and
empowering champions, and providing feedback and positive reinforcement (Gesme &
Wiseman, 2010). All health practitioners involved in this project received clear verbal or
nonverbal information regarding the project at regular intervals about the project's plan, progress,
and success. Charge nurses were aware to check VAPB compliance in each shift. Any successful
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organizational change plan relies on effective communication (Melnyk & Fineout-Overholt,
2019).
Evidence-based nursing is intended to standardize health care practices to the latest and
the best science available in order to minimize variations in care and avoid unanticipated health
outcomes (Correa-de-Araujo, 2016). Each element of the VAPB serves to keep critically ill,
mechanically ventilated patients safe while hospitalized.
Timetable/Flowchart
VAP is a preventable illness that compromises the lives of patients in critical care units
globally. EBP change project timelines are highly varied, and multiple project components may
overlap or occur at the same time (Melnyk & Fineout-Overholt, 2019). The plan for the current
project started on January 13, 2020. The PICOT question was developed in the previous
semesters and gained approval from the critical care director. Research and relevant clinical
information were established and gathered pertinent to the patient population, and data was
acquired to support the need for evidence-based change. Once the evidence was obtained, a
synthesis table was created.
During the first week, approval was gained from the critical care director at the facility to
obtain the data required for the project. Week two through five consisted of collecting current
VAPB compliance rates starting from September 5 to October 2. As week three through four
progressed, staff and stakeholder engagement was encouraged from October 3 through the 9th.
Critical care meetings and selection team leaders occurred from October 10 through the 16th.
During week five, practice recommendations required for the Evidence-Based practice were
formulated from September 12 through September 18. The following week consisted of meetings
amongst team leaders to create visual reminders and posters to engage staff and properly follow
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VAPB care. The following week, Stakeholder’s approval was gained. During this period, team
leaders put forth efforts to type and place placards for every computer in the ICU and reminder
stickers on the computer monitors. Before this occurred, a meeting was held so that all team
members were aware and individual roles and expectations were set, given proper education.
Weeks eight through 11 consisted of implementing a revised formulation for VAPB.
Team leaders collected daily compliance data reflecting VAPB adherence. The consecutive week
used for final data collection analyzes pre and post-intervention figures for VAP adherence in the
unit. The data was then shared with stakeholders, followed by disseminating the evidence.
During next month’s critical care meeting, there will be more face-to-face communication with
nursing professionals. This meeting will be four different sections for all staff from the day and
night shifts. Roundtable presentations offer the opportunity to share specific information with a
group but also to allow the group to discuss the practical application of the content outcomes
(Melnyk & Fineout-Overholt, 2019). Once this meeting is over, information about the evidence
will send it as a message to the critical care group. Another option is to disseminate the findings
to the hospital board, including all healthcare professionals involved in critical-care patient care.
Data Collection Methods
From the conception phase to the conclusion phase, good research technique design is
critical, and computers play an essential role from the beginning to the finish of a study,
particularly for data collection, data storage, and data administration ((Kulkarni, 2016). DRMC
uses epic software, which is very helpful for collecting data regarding the components of the
VAPB.
The current evidence-based project was the implementation of a revised VAPB at regular
intervals in SICU. After providing care to the patient, staff recorded the event into the electronic
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health record (EHR). A checklist was also used for assessing VAPB compliance. Head of the bed
elevation, oral suction, and oral care was checked every four hours and considered done if
checked "yes" all six times. Peptic ulcer disease prophylaxis and deep venous thrombosis
prophylaxis, assessment of readiness to extubate, sedation vacations were verified if completed
or not daily. Cuff pressure assessment was done at least once in a shift. The case is not in
compliance with the bundle if even one element is missing. For example, the SICU has 14 beds.
If there are 14 ventilated patients, and ten patients have all bundle elements completed, 71
percent (10 divided by 14 multiplied by 100) are compliant with the ventilator bundle. If all 14
patients had all bundle elements completed, compliance would be 100 percent. The entire bundle
is considered compliant only if all items were compliant, and it is considered non-compliant if
any item was not performed (Bird, 2010).
Charts of mechanically ventilated patients were reviewed daily to assess the VAPB
compliance rate. SICU always has free charge nurses, and they agreed to check it to make the
project a success. The critical care charge nurses kept track of the number of days patients spent
on a ventilator and VAPB compliance daily and recorded it on a checklist. A ventilator day is
defined as a calendar day for which the patient is charged for mechanical ventilation (Bird,
2010). The formula for calculating VAPB per 1000 ventilator days was in place ("Ventilator
Bundle Compliance | IHI - Institute for Healthcare Improvement," n.d.). The formula for
calculating VAPB compliance is (number of SICU patients on mechanical ventilation who
received all ventilator bundle elements) / (total number of SICU patients on mechanical
ventilation on a given day of the week of the sample) and multiply by 100 to obtain percentage
("Ventilator Bundle Compliance | IHI - Institute for Healthcare Improvement," n.d.).
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VAPB compliance rates of every Saturday during pre-and post-intervention were used to
compare the rate and success of the project. The weekly data collection was displayed using a
bar graph. The pre-implementation was comprehensively evaluated in the same SICU for the
previous four weeks' VAPB compliance rates.
Nurses intervened in this process when monitoring if non-compliance with a bundle
element was detected and regular feedback on compliance was provided to the ICU teams (Eom
et al., 2014). The hospital approved all study procedures. Outcome data were collected daily to
determine whether 100 % adherence was followed for the VAPB implementation and the result
posted on the notice board in the critical care unit. These results helped all staff members
understand what is going on and where the missing is happening.
Cost/Benefit Discussion
The current project does not add any additional cost to the hospital's budget because of
multiple reasons. All products used were already included in the unit budget; therefore, the
expenses remained the same. SICU required sufficient staffing; the nurse-to-patient ratio usually
was 1:2 in SICU, although in some cases, such as patients with an impella or IABP, the ratio was
1:1. There was no modification to the number of staff required for this project. According to
(Fratantoro, 2013) a study conducted by researchers from Brigham and Women's Hospital and
Harvard Medical School reveals that VAP accounts for 31.6% of total healthcare-associated
infections, and the United States (US) healthcare system spends $40,144 per patient to treat
VAP. Comprehensive nurse intervention can reduce the time spent on mechanical ventilation and
in the hospital, avoid VAP, alleviate patients' negative emotions, and improve their quality of life
as well as nursing satisfaction (Fan, Chu, Jiang, & Du, 2021). Patient healthcare costs will be
reduced due to the reduced length of stay in the hospital due to VAP prevention.
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Discussion of Results
Health outcome measures are used to assess clinical practice changes, aid in healthcare
decision-making, and develop new policies or practice standards (Melnyk & Fineout-Overholt,
2019). The VAPB compliance rate was required to ensure that all patients received effective
treatment in the hospital. In total, there were 194 ventilator days included in the study.
Throughout the study period, there was an overall rise in compliance with the bundle in SICU.
The VAPB compliance rate in each week during the pre-intervention period was 69.2%, 55.5%,
70%, and 71.4%, whereas, in the post-intervention period, it rose to 83.3%, 88.8%, 100%, and
90% consecutively. Overall compliance with the VAP bundle increased from 66.5% to
90.5% within the SICU. During the VAPB implementation period, VAPB compliance reached
100 % on several days, but on other days it was not. The main reason was that because of
COVID- 19, many patients’ oxygen requirements and positive end-expiratory pressure (PEEP)
were very high, and sedation vacation was impossible. There was no possibility to compare the
effect of VAPB for the occurrence of VAP due to pandemic because almost all patients’
diagnosis was pneumonia at the time of admission.
Conclusions/Recommendations
Due to lengthy hospital stays, VAP patients face astronomical hospital expenditures and
are forced to spend more time away from their families than is necessary. There are some
recommendations for this project. Understanding how VAP can be reduced would help patients
live longer, have a better quality of life, and reduce hospital liability. Once the pandemic is over,
more research is needed to confirm the effectiveness of VAPB for the prevention of VAP.
Research studies have shown positive effects of using the VAPB for the prevention of VAP.
Therefore, adhering to a VAPB at regular intervals in the critical care unit is recommended to
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improve patient outcomes and save money for both the patient and the hospital. Health education
played an integral role in maintaining compliance rates for VAPB, while in-service education
and continuation of learning will allow for VAP rates to stay low or remain close to zero. Strict
adherence to VAPB needs to become the standard of practice that helps enforce a patient safety
culture for all healthcare workers.
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Appendix A
Evidence Synthesis Table
Studies
A

Design
Methodological

Sample
N= 1003

B

Qualitative
descriptive

N= 23

C

Single-blind
clinical trial study
Quasiexperimental

N= 100

E

Cohort

N= 4000

F

Descriptive

D

N= 196
ICU beds

Intervention
HOBE
DSV
PUP
DVTP
OC
OS
Nurses perception about
barriers for VAPB
intervention
DSV

Outcome
VBC increased
VAPR decreased
VUR increased

HOBE
PUP
DVTP
OC
HOBE
EA
DSV
PUP
DVTP
HOBE
OC
AS
PUP
CPC

VBC increased
VAPR decreased

Barriers present

VAPR decreased

TBC increased
VAPR decreased

VBC increased
VAPR decreased
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Appendix A: Continued
Evidence Synthesis Table
ETS
EOC
HOBE
OC
CPC
Keep breathing circuit below
bed height
DSV

G

Quasi-experimental

N= 1000
PD

H

Quasi-experimental

N= 2200
patients
annually

HOBE
DSV
EA
PUP
DVTP
OC
CASS

VAPR decreased

I

Cohort study

N= 3845

No circuit change
DSV
Hand hygiene
OC
CPC

VAPR decreased
ICU LOS
Duration of MV

VD

J

K

L

VAPR decreased
HCAI decreased

Single-blind
prospective
randomized clinical
trial
Cohort study

N= 25

HOBE 45O
HOBE 60O

VAPR decreased

N= 171,
237 ICU
admissions

VAPR decreased

Prospective,
randomized,
controlled

N= 60

Education
Hand hygiene
CPC
OC
HOBE
Reduce DMV
HOBE <30o
HOBE 30o
HOBE 45o

Percentage of VAP is
low
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Appendix A: Continued
Evidence Synthesis Table
Legend: A = Balkhy et al., 2014, B = Atashi et al., 2017, C = Shahabi et al., 2017, D = Eom et
al., 2014, E = Bird et al., 2010, F = Mahmudin et al., 2020, G = Fortaleza et al., 2020, H =
Caserta et al., 2012, I = Rello et al., (2013), J = Hassankhani et al., 2017, K = Álvarez-Lerma et
al., 2018, L = Güner & Kutlutürkan, 2021.
AS - assessment of sedation, CASS – continuous aspiration of subglottic secretion, CPC - cuff
pressure control, DMV- duration of mechanical ventilation, DSV- daily sedation vacation,
DVTP - deep vein thrombosis prophylaxis, , EA – extubation assessment, EOC - emptying of
condensate, ETS – endotracheal tube suctioning, HCAI - healthcare associated infections,
HOBE – head of bed elevation, ICU- Intensive care unit, OC- oral care, OS – oral suction, PD patient days, PUP - peptic ulcer prophylaxis, TBC - total bundle compliance, VAPB ventilator associated pneumonia bundle VAPR – ventilator associated pneumonia rate, VBC –
ventilator bundle compliance bundle compliance, VD- ventilator days, VUR- ventilator
utilization ratio.
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Appendix B
Outcomes Table: Effect of ventilator-associated pneumonia bundle for the prevention of
ventilator-associated pneumonia
A

B

VBC

↑

VAPR

↓

NE

C ♦

↓

D ♦

E

G ♦

F

↑

↑

↑

↓

⃰ ↓

↓

↓

H

↓

I

J

↓

K

↓

L

↓

Legend: A = Balkhy et al., 2014, B = Atashi et al., 2017, C = Shahabi et al., 2017, D = Eom et
al., 2014, E = Bird et al., 2010, F = Mahmudin et al., 2020, G = Fortaleza et al., 2020, H =
Caserta et al., 2012, I = Rello et al., 2013, J = Hassankhani et al., 2017, K = Álvarez-Lerma et
al., 2018, L = Güner & Kutlutürkan, 2021. NE-not evaluated, VAPR - ventilator associated
pneumonia rate, VBC - – ventilator bundle compliance
* = statistically significant findings
♦ = higher level evidence
VAPR – ventilator-associated pneumonia
VBC - ventilator bundle compliance

↓
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Appendix B
Flowchart
Previous semesters
 Developed PICOT question
 Initial approval from critical care director
 Research and relevant information were established
 Synthesis table was created

Week 5
Formulated practice
recommendations

Week 6
Meeting with team leaders and
assigned their roles

Week 12
Measure clinical outcomes

Week 13
Discussion with stake holders

Week 2 - 5
Collected VAPB compliance data
for four weeks





Week 3 -4
Staff and stake holder
engagement
Critical care meetings
Selection of team leaders

Week 1
Approval from critical care
director to collect data

Week 7
 Approval from stake holders
 Created posters for SICU
 Visual reminder for the steps
of VAPB pasted

Week 8 – 11
Implementation of revised
VAPB care

Week 14
Disseminate evidence
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Appendix C
Instrument
Checklist for VAPB compliance
Serial
number

VAPB elements

Bed number
1

1

2
3

4
5
6
7
8

Daily assessment of
readiness to extubate,
yes/no
Daily sedation vacation,
yes/no
Daily peptic ulcer
disease prophylaxis
yes/no
Deep vein thrombosis
prophylaxis, yes/no
Cuff pressure
assessment, yes/no
Semi-recumbent position
(more than 30 degrees)
Oral suction every four
hours, yes/no
Oral care every four
hours, yes/no

2

3

5

5 7

8

9

10 11 11 12 14 15
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Appendix D
Outcome
Percentage of VAPB compliance rate
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Pre intervention
Post intervention
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